SynthesisPloS one2023

Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials.

Shangtong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.